Lee Karras is an established pharmaceutical business executive with over twenty five years of healthcare industry related experience. Prior to joining Halo, Lee held executive leadership roles in several businesses. Most recently he was President of IBA Molecular North America, a global leader in the manufacture and distribution of generic radiopharmaceuticals. Prior to IBA Molecular, Lee spent four years with AAIPharma Services where he was hired to reestablish the CDMO from bankruptcy and did so culminating in a successful $50MM sale to a private equity firm in 2009. Mr. Karras also spent 15 years with Cook Pharmaceutical Services and then Baxter Biopharma Solutions managing those successful CDMO businesses helping build the Baxter business into an a $200MM+ business during his tenure. Lee has a proven track record of building scalable, yet cost effective businesses as well as managing complex contract research, manufacturing and pharmaceutical services businesses. Having worked in the contract pharmaceutical services industry over the last two decades, Lee has had to adapt and develop new business models to keep pace with the ever changing pharmaceutical landscape. Lee holds a bachelors degree in Chemistry and an MS in Environmental Science, both from Indiana University in Bloomington.
Interested in Business Management.